Comparison of different Aspirin in diabetic patients.
Phase 4
Completed
- Conditions
- Health Condition 1: null- Patients with Type 2 DM receiving oral anti-diabetic and who have two or more risk factors for cardiovascular disease
- Registration Number
- CTRI/2017/09/009673
- Lead Sponsor
- Dr Kanharam Patel
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 121
Inclusion Criteria
Patients with Type 2 DM receiving oral anti-diabetic with dietary modifications and who have two or more risk factors for cardiovascular disease.
Exclusion Criteria
Patients having age <40 yrs.
Uncontrolled diabetes mellitus (Fasting BSL > 300 mg/dL Despite therapy)
Uncontrolled Hypertension
Abnormal Liver Function Tests and/or Renal Function Tests.
Patients receiving any form or dose of Aspirin therapy for >7 days
Patient receiving any other antithrombotic or anti-coagulant therapy.
Patients having deranged bleeding and/ or clotting time at baseline study.
Patient on insulin.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ADP induced platelet aggregationTimepoint: Day 0 Day 15
- Secondary Outcome Measures
Name Time Method Bleeding Time <br/ ><br>Steady state plasma salicylate concentrationTimepoint: Day 0 Day 15